Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 5
2006 8
2007 11
2008 9
2009 9
2010 9
2011 14
2012 7
2013 8
2014 9
2015 10
2016 9
2017 10
2018 17
2019 16
2020 11
2021 8
2022 5
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Results by year

Filters applied: . Clear all
Page 1
Successful treatment of a chemotherapy-resistant t(17;19) paediatric ALL with a combination of inotuzumab, venetoclax and navitoclax.
Gottardi F, Baccelli F, Leardini D, Di Battista A, Castellucci P, D'Amico D, Serravalle S, Bertuccio SN, Messelodi D, Prete A, Masetti R. Gottardi F, et al. Among authors: castellucci p. Br J Haematol. 2023 Sep;202(5):e39-e42. doi: 10.1111/bjh.18936. Epub 2023 Jun 22. Br J Haematol. 2023. PMID: 37350036 No abstract available.
68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study.
Mei R, Kessler L, Pabst KM, Weber M, Schmidkonz C, Rischpler C, Zacho HD, Hope T, Schwarzenböck SM, Allen-Auerbach M, Emmett L, Ferdinandus J, Unterrainer M, Schaarschmidt BM, Umutlu L, Farolfi A, Castellucci P, Nanni C, Telo S, Fanti S, Herrmann K, Fendler WP. Mei R, et al. Among authors: castellucci p. J Nucl Med. 2023 Jul;64(7):1043-1048. doi: 10.2967/jnumed.122.265245. Epub 2023 May 25. J Nucl Med. 2023. PMID: 37230530
PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment.
Bianchi L, Ceci F, Balestrazzi E, Costa F, Droghetti M, Piazza P, Pissavini A, Presutti M, Farolfi A, Mei R, Castellucci P, Gandaglia G, Larcher A, Robesti D, Mottrie A, Briganti A, Morganti AG, Fanti S, Montorsi F, Schiavina R, Brunocilla E. Bianchi L, et al. Among authors: castellucci p. Cancers (Basel). 2023 Mar 29;15(7):2027. doi: 10.3390/cancers15072027. Cancers (Basel). 2023. PMID: 37046687 Free PMC article.
Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68Ga-PSMA PET/CT Features in Primary Staging.
Vetrone L, Mei R, Bianchi L, Giunchi F, Farolfi A, Castellucci P, Droghetti M, Presutti M, Degiovanni A, Schiavina R, Brunocilla E, D'Errico A, Fanti S. Vetrone L, et al. Among authors: castellucci p. Cancers (Basel). 2023 Mar 10;15(6):1716. doi: 10.3390/cancers15061716. Cancers (Basel). 2023. PMID: 36980602 Free PMC article.
164 results